Feihe fourth quarter revenues increased 41.6% to $62.3 million

NewsGuard 100/100 Score

Feihe International, Inc. (NYSE: ADY; "Feihe International" or the "Company") (formerly known as American Dairy, Inc.), one of the leading producers and distributors of premium infant formula, milk powder and soybean, rice and walnut products in China, today announced unaudited financial results for the fourth quarter and full year ended December 31, 2010.  The Company will hold a conference call today at 9:00 am ET.

Fourth Quarter 2010 Financial Highlights:

  • Exceeding guidance, revenue increased 41.6% to $62.3 million from $44.0 million in 4Q 2009
    • Revenue from branded milk powder products was $39.5 million, or 63.4% of total sales, in 4Q 2010 vs. $20.7 million, or 47.0% of total sales, in 4Q 2009
    • Revenue from raw milk powder was $17.3 million, or 27.8% of total sales, in 4Q 2010 vs. $18.9 million, or 43.0% of total sales, in 4Q 2009
  • Gross profit increased to $19.0 million from a loss of $(3.0) million in 4Q 2009
  • Gross margin was 30.5% in 4Q 2010 vs. a loss of (6.8%) in 4Q 2009
  • Net income increased to $1.9 million from a loss of $(27.0) million in 4Q 2009
  • Diluted EPS per common share increased to $0.04 from a loss of $(1.24) in 4Q 2009.

Mr. Leng You Bin, the Company's Chairman and Chief Executive Officer, stated, "Our results of $62.3 million in revenue and $1.9 million in net income are excellent indications of our footprint in the competitive Chinese milk powder industry.  We are continuing to make improvements in our operations across our sales and marketing, including improving the cost effectiveness of our selling expenses and increasing sales at existing retail sales points to drive greater profitability.  We are also pleased to announce that we renewed our manufacturing license with the Heilongjiang Bureau of Quality and Technical Supervision.  The renewal permit was granted under regulatory measures introduced by the General Administration of Quality Supervision, Inspection and Quarantine of China in late 2010. According to these new measures, infant formula and dairy product companies that fail to obtain the renewal manufacturing license by the end of March 2011 must cease production.  As one of the dairy companies which consistently provide safe and higher premium quality products, we welcome stricter regulation in the dairy industry and we believe that we are well positioned to execute our strategic initiatives to grow sales at existing retail sales points throughout 2011 and capitalize on market opportunities."  

The increase in revenue in the fourth quarter of 2010 compared to the fourth quarter of 2009 was primarily attributable to an increase in sales of branded milk powder, as well as the continued commitment to making improvements across all functions including effectiveness of operations.  The revenue in the fourth quarter of 2010 increased 2.0% sequentially from $61.1 million in the third quarter of 2010, primarily reflecting the Company's efforts to increase sales at existing retail sales points.

Gross profit was $19.0 million in the fourth quarter of 2010 compared to a loss of $(3.0) million in the fourth quarter of 2009.  Gross margin for the fourth quarter of 2010 was 30.5%, compared to a loss of (6.8%) in the fourth quarter of 2009, which was primarily due to an increase in sales of branded milk powder with a higher margin and a decrease in sales of raw milk powder with a lower margin, and also due to improvements in the Company's marketing and selling operations.

In the fourth quarter of 2010, the Company had an operating loss of $(11.3) million, compared to an operating loss of $(35.4) million in the fourth quarter of 2009, despite an impairment of $1.4 million recognized in the fourth quarter of 2010 related to Shanxi Feihe as a result of the stagnating growth of our walnut powder products.  Reduction of operating loss in the fourth quarter of 2010 was primarily due to a 9.5% decrease of sales and marketing expenses to $22.9 million in the fourth quarter of 2010 from $25.3 million in the fourth quarter of 2009, primarily reflecting a decrease in promotional fees and advertisement and the Company's efforts to improve the effectiveness of its selling expenses and sales at existing sales points instead of expanding its distribution network.  General and administrative expenses increased 34.3% to $4.7 million in the fourth quarter of 2010 from $3.5 million in the fourth quarter of 2009, primarily reflecting increased salary, professional service fees and travelling expenses.

The Company recognized other income of $12.0 million during the fourth quarter of 2010, compared to  other income of $4.2 million during the fourth quarter of 2009. The higher other income was primarily driven by additional government subsidy and a reduction of interest and finance costs.

Net income attributable to the Company for the fourth quarter of 2010 was $1.9 million, or diluted EPS per common share of $0.04, improving significantly from net loss attributable to the Company of $(27.0) million, or diluted EPS per common share of $(1.24), in the fourth quarter of 2009.

Full Year Ended December 31, 2010 Financial Highlights:

Revenue decreased 5.2% to $257.1 million during the year ended December 31, 2010 from $271.1 million during the year ended December 31, 2009. Contributions from branded milk powder products were approximately $180.2 million, or 70.1% of total sales during the year ended December 31, 2010, down 16.7% from $216.2 million, or 79.7% of total sales, in the corresponding period in 2009. This decrease was primarily due to increased competition from new competitors entering into Chinese dairy industry and old competitors aggressively attempting to reclaim market share following the melamine crisis. During the year 2010, the Company slowed its expansion efforts and strategically adjusted its distribution network throughout China to focus on improving sales at existing sales points.  Gross profit decreased 21.0% to $103.3 million during the year ended December 31, 2010 from $130.7 million in the same period of 2009. Gross margin for the year ended December 31, 2010 was 40.2%, compared to 48.2% during the year ended December 31, 2009, primarily attributable to increases in the price for both internally and externally sourced raw materials, and also to a decrease in sales of branded milk powder with a higher margin and an increase in sales of raw milk powder with a lower margin.  Operating loss was $(31.0) million in the full year ended December 31, 2010, compared to a profit of $2.4 million in the corresponding period in 2009, the decrease was partially attributable to a loss on disposal of biological assets for an amount of $10.2 million. Net income attributable to the Company for the full year ended December 31, 2010 decreased to a loss of $(9.6) million, or diluted EPS per common share of $(0.48), from a profit of $19.6 million, or diluted EPS per common share of $0.97, in the corresponding period in 2009.

As of December 31, 2010, the Company had cash and cash equivalents of $17.5 million and total current assets of $137.2 million, compared with cash and cash equivalents of $48.2 million and total current assets of $159.2 million as of December 31, 2009. The Company believes that it has sufficient cash and cash flows from operations to adequately support its business in the next operating cycle, subject to the renewal of its $69.3 million short-term loan.

Financial Guidance

Mr. Liu Hua, the Company's Acting Chief Financial Officer, stated, "We are pleased to report our fourth quarter and full year 2010 financial results.  As we approach the end of the first quarter of 2011, we are confident that we are taking effective measures to continue to improve our operations across all functions.  Based on cash and actual purchase orders received this quarter to date and management's estimates, we project our total revenue will be approximately $290 million and net income will be approximately $22 - $24 million in the full year of 2011."

SOURCE Feihe International, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
MD Anderson and CureVac collaborate on mRNA-based cancer vaccines